{
    "2021-01-04": [
        [
            {
                "time": "",
                "original_text": "康泰生物(300601.SZ)遭监事会主席吕志云减持6.7万股 减持数量过半 减持股份",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "监事会主席",
                        "减持",
                        "6.7万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：监事会主席减持0.01%股份，减持数量过半 减持股份",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "监事会主席",
                        "减持",
                        "0.01%股份"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业疫苗子行业跟踪点评：国药灭活新冠疫苗附条件批准上市",
                "features": {
                    "keywords": [
                        "医药行业",
                        "疫苗",
                        "国药",
                        "灭活新冠疫苗",
                        "附条件批准上市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【医药】新冠疫苗附条件上市，行业确定性逐步明晰——医药行业周报——中性",
                "features": {
                    "keywords": [
                        "医药行业",
                        "新冠疫苗",
                        "附条件上市",
                        "行业确定性"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}